These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11120709)

  • 1. High antifibrinolytic activity of lipoprotein(a) containing small apolipoprotein(a) isoforms.
    Anglés-Cano E
    Circulation; 2000 Dec; 102(25):E184-5. PubMed ID: 11120709
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipoprotein(a) concentration and apolipoprotein(a) size: A synergistic role in advanced atherosclerosis?
    Marcovina SM; Koschinsky ML
    Circulation; 1999 Sep; 100(11):1151-3. PubMed ID: 10484533
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.
    Kronenberg F; Kronenberg MF; Kiechl S; Trenkwalder E; Santer P; Oberhollenzer F; Egger G; Utermann G; Willeit J
    Circulation; 1999 Sep; 100(11):1154-60. PubMed ID: 10484534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lipoprotein(a): importance for the fibrinolytic system and thromboembolic complications].
    Leischik R; Dworrak B
    Herz; 2006 Apr; 31(2):144-52. PubMed ID: 16738838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein(a) and atherosclerosis.
    Ishibashi S
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):1-2. PubMed ID: 11145926
    [No Abstract]   [Full Text] [Related]  

  • 6. Lipoprotein(a) level as a predictor of cardiovascular disease and small apoliprotein(a) isoforms in dialysis patients: assay-related differences are important.
    Longenecker JC; Coresh J; Klag MJ; Powe NR; Fink NE; Marcovina SM
    Clin Chim Acta; 2008 Nov; 397(1-2):36-41. PubMed ID: 18692032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lipoprotein(a) and Apo-A isoforms in patients with intermittent claudication].
    Britareva VV; Afanas'eva OI; Dobrovol'skiĭ AB; Ezhov MV; Titaeva EV; Karpov IuA; Pokrovskiĭ SN
    Ter Arkh; 2002; 74(12):49-52. PubMed ID: 12577841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) and apoliprotein (a) isoform size in thyroid disease: the quest for the golden fleece.
    Duntas LH
    Thyroid; 2003 Apr; 13(4):345-6. PubMed ID: 12812213
    [No Abstract]   [Full Text] [Related]  

  • 9. [Apolipoprotein(a)--a marker of the atherosclerotic process].
    Titov VN
    Ter Arkh; 1993; 65(12):79-82. PubMed ID: 7511838
    [No Abstract]   [Full Text] [Related]  

  • 10. Structure and metabolism of lipoprotein (a).
    Marcovina SM; Morrisett JD
    Curr Opin Lipidol; 1995 Jun; 6(3):136-45. PubMed ID: 7648002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of mutations in human apolipoprotein(a) kringle 4-37 from the study of the DNA of peripheral blood lymphocytes: relevance to the role of lipoprotein(a) in atherothrombosis.
    Scanu AM
    Am J Cardiol; 1995 Feb; 75(6):58B-61B. PubMed ID: 7863976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a)-lowering therapies: a double edged sword?
    Lippi G
    Atherosclerosis; 2015 Oct; 242(2):504-5. PubMed ID: 26298742
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of lipoprotein (a) phenotypes in Ivorian subject].
    Tiahou G; Aveynier E; Djessou P; Sess D; Cristol JP
    Bull Soc Pathol Exot; 2005 Jun; 98(2):99-103. PubMed ID: 16050374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
    Horejsí B; Ceska R
    Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein a polymorphism predicts lipoprotein a concentration in renal transplant recipients.
    Argani H; Ghorbanihaghjo A; Rashtchizadeh N; Rahbaninobar M
    Transplant Proc; 2005 Sep; 37(7):2925-8. PubMed ID: 16213263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for the presumptive atherothrombogenic action of lipoprotein(a). Facts and speculations.
    Scanu AM
    Biochem Pharmacol; 1993 Nov; 46(10):1675-80. PubMed ID: 8250952
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipoprotein[a]: a predictor of atherosclerotic disease.
    Harris ED
    Nutr Rev; 1997 Mar; 55(3):61-4. PubMed ID: 9170891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism for the homocysteine-enhanced antifibrinolytic potential of lipoprotein(a) in human plasma.
    Nardulli M; Durlach V; Pepe G; Anglés-Cano E
    Thromb Haemost; 2005 Jul; 94(1):75-81. PubMed ID: 16113787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure.
    Kimak E; Solski J
    Ren Fail; 2002 Jul; 24(4):485-92. PubMed ID: 12212828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.